CVS Health Corporation (NYSE:CVS) Stake Decreased by NS Partners Ltd
NS Partners Ltd reduced its position in CVS Health Corporation (NYSE:CVS) by 96.6% during the first quarter, according to its most recent filing with the SEC. The institutional investor owned 3,251 shares of the pharmacy operator’s stock after selling 93,223 shares during the period. NS Partners Ltd’s holdings in CVS Health Corporation were worth $255,000 at the end of the most recent reporting period.
Several other hedge funds and other institutional investors also recently modified their holdings of the company. Mercer Capital Advisers Inc. bought a new position in shares of CVS Health Corporation during the first quarter worth approximately $118,000. Orrstown Financial Services Inc. boosted its position in shares of CVS Health Corporation by 2,000.0% in the first quarter. Orrstown Financial Services Inc. now owns 2,100 shares of the pharmacy operator’s stock worth $165,000 after buying an additional 2,000 shares during the last quarter. SRS Capital Advisors Inc. boosted its position in shares of CVS Health Corporation by 48.2% in the first quarter. SRS Capital Advisors Inc. now owns 2,256 shares of the pharmacy operator’s stock worth $177,000 after buying an additional 734 shares during the last quarter. Edmp Inc. bought a new position in shares of CVS Health Corporation during the first quarter worth approximately $202,000. Finally, Pinnacle Bank bought a new position in shares of CVS Health Corporation during the first quarter worth approximately $203,000. Institutional investors own 81.92% of the company’s stock.
CVS Health Corporation (NYSE CVS) traded up 0.11% during trading on Thursday, hitting $79.52. The company had a trading volume of 784,048 shares. The stock has a market capitalization of $80.71 billion, a price-to-earnings ratio of 15.85 and a beta of 0.91. The company’s 50 day moving average price is $78.74 and its 200-day moving average price is $78.97. CVS Health Corporation has a 1-year low of $69.30 and a 1-year high of $98.44. CVS Health Corporation also was the target of unusually large options trading on Monday. Stock traders acquired 12,222 put options on the stock. This represents an increase of approximately 254% compared to the typical volume of 3,454 put options.
CVS Health Corporation (NYSE:CVS) last released its quarterly earnings data on Tuesday, August 8th. The pharmacy operator reported $1.33 earnings per share for the quarter, topping the consensus estimate of $1.31 by $0.02. CVS Health Corporation had a return on equity of 17.47% and a net margin of 2.93%. The business had revenue of $45.69 billion during the quarter, compared to analysts’ expectations of $45.36 billion. During the same quarter last year, the business posted $1.32 EPS. The business’s revenue was up 4.5% on a year-over-year basis. On average, analysts expect that CVS Health Corporation will post $5.88 EPS for the current year.
The firm also recently disclosed a quarterly dividend, which was paid on Thursday, August 3rd. Shareholders of record on Monday, July 24th were issued a $0.50 dividend. This represents a $2.00 annualized dividend and a yield of 2.52%. The ex-dividend date of this dividend was Thursday, July 20th. CVS Health Corporation’s dividend payout ratio (DPR) is currently 39.92%.
COPYRIGHT VIOLATION NOTICE: This article was reported by Daily Political and is owned by of Daily Political. If you are viewing this article on another website, it was stolen and republished in violation of U.S. & international copyright & trademark legislation. The legal version of this article can be accessed at https://www.dailypolitical.com/2017/08/10/cvs-health-corporation-nysecvs-stake-decreased-by-ns-partners-ltd.html.
CVS has been the topic of a number of recent analyst reports. Leerink Swann set a $90.00 target price on CVS Health Corporation and gave the company a “buy” rating in a research report on Tuesday, June 27th. Vetr cut CVS Health Corporation from a “strong-buy” rating to a “buy” rating and set a $88.97 target price on the stock. in a research report on Monday, June 12th. Tigress Financial initiated coverage on CVS Health Corporation in a research report on Thursday, April 27th. They issued a “buy” rating on the stock. Guggenheim reiterated a “buy” rating on shares of CVS Health Corporation in a research report on Monday, July 3rd. Finally, ValuEngine cut CVS Health Corporation from a “buy” rating to a “hold” rating in a research report on Friday, June 2nd. Eight equities research analysts have rated the stock with a hold rating and thirteen have given a buy rating to the company. The stock presently has an average rating of “Buy” and a consensus price target of $91.27.
In other CVS Health Corporation news, EVP Helena Foulkes sold 20,333 shares of the stock in a transaction that occurred on Monday, June 26th. The stock was sold at an average price of $80.00, for a total value of $1,626,640.00. Following the completion of the sale, the executive vice president now owns 59,301 shares in the company, valued at approximately $4,744,080. The transaction was disclosed in a document filed with the SEC, which is available at this link. Also, CFO David M. Denton sold 230,510 shares of the stock in a transaction that occurred on Monday, June 12th. The stock was sold at an average price of $80.00, for a total value of $18,440,800.00. Following the completion of the sale, the chief financial officer now owns 176,983 shares of the company’s stock, valued at approximately $14,158,640. The disclosure for this sale can be found here. In the last quarter, insiders sold 271,175 shares of company stock valued at $21,632,597. Company insiders own 0.61% of the company’s stock.
CVS Health Corporation Company Profile
CVS Health Corporation, together with its subsidiaries, is an integrated pharmacy healthcare company. The Company provides pharmacy care for the senior community through Omnicare, Inc (Omnicare) and Omnicare’s long-term care (LTC) operations, which include distribution of pharmaceuticals, related pharmacy consulting and other ancillary services to chronic care facilities and other care settings.
Want to see what other hedge funds are holding CVS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CVS Health Corporation (NYSE:CVS).
Receive News & Ratings for CVS Health Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CVS Health Corporation and related companies with MarketBeat.com's FREE daily email newsletter.